Coronavirus • 09 April, 2020

Kazakh scientists on coronavirus vaccine

10 time viewed

Research Institute for Biological Safety Problems and National centre for biotechnology are developing a vaccine from coronavirus infection,  General Director of Research Institute for Biological Safety Problems says.

54 vaccines are currently being developed by states, of which two have entered the clinical trial stage the WHO says.

In total, 4 vaccines are planned to develop, 2 of which are vector-based and 2 are subunit-based based on fragments of the virus S-protein.

After preclinical and clinical trials, the most effective and safe of them will be selected.

Scientists are working in laboratories of the 3rd level of BSL-3 biosecurity on real strains of SARS-CoV-2 coronavirus.

The Institute has an agreement with the World Health Organization to develop vaccines against particularly dangerous infections for public health.

Last news

2.6 million students to study in distance

Education • 06 August, 2020

375 people died from coronavirus infection

Coronavirus • 13 July, 2020

Turkey sends humanitarian aid to Kazakhstan

Coronavirus • 13 July, 2020

Kazakhstan mourns Covid-19 victims today

Kazakhstan • 13 July, 2020

How the main city of Kazakhstan developed

Kazakhstan • 08 July, 2020

Russian doctors arrive in Kazakhstan

Coronavirus • 07 July, 2020

Nursultan Nazarbayev marks his 80th birthday

Елбасы • 07 July, 2020

Similar news